Literature DB >> 231907

Partial trisomy 20 confirmed by gene dosage studies.

N L Rudd, H W Bain, E Giblett, S H Chen, R G Worton.   

Abstract

We describe a female infant with multiple congenital anomalies and mental retardation, pre- and postnatal growth failure, microcephaly, unusual facial appearance, and minor skeletal anomalies, all very suggestive of the partial trisomy 20(p) syndrome. Although she was born to karyotypically normal parents, she had an extra small metacentric chromosome. Analysis of metaphase and prometaphase chromosomes by GTG banding and Giemsa 11 staining showed that the extra chromosome was a number 20 with a deletion of the distal end of the long arm. Gene dose studies of adenosine deaminase (ADA) and inosine triphosphatase (ITP) supported the cytogenetic interpretation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 231907     DOI: 10.1002/ajmg.1320040407

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

Review 1.  The map of chromosome 20.

Authors:  N E Simpson
Journal:  J Med Genet       Date:  1988-12       Impact factor: 6.318

2.  Partial trisomy 20p resulting from a recombination of a familial pericentric inversion.

Authors:  N Bown; I Cross; E V Davison; J Burn
Journal:  Hum Genet       Date:  1986-12       Impact factor: 4.132

3.  Segregation of a t(3;20) translocation through three generations resulting in unbalanced karyotypes in six persons.

Authors:  K B Nielsen; N Tommerup; B Jespersen; P Nygaard; L Kleif
Journal:  J Med Genet       Date:  1986-10       Impact factor: 6.318

4.  Genetic mapping: chromosomes 6-22.

Authors:  B Keats
Journal:  Am J Hum Genet       Date:  1982-09       Impact factor: 11.025

5.  Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene.

Authors:  T M Berkvens; E J Gerritsen; M Oldenburg; C Breukel; J T Wijnen; H van Ormondt; J M Vossen; A J van der Eb; P Meera Khan
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.